These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6228566)

  • 21. Effect of luteinizing hormone releasing hormone (LHRH) and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide on alpha-subunit and LH beta messenger ribonucleic acid levels in rat anterior pituitary cells in culture.
    Hubert JF; Simard J; Gagné B; Barden N; Labrie F
    Mol Endocrinol; 1988 Jun; 2(6):521-7. PubMed ID: 2458526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
    Lahlou N; Roger M; Chaussain JL; Feinstein MC; Sultan C; Toublanc JE; Schally AV; Scholler R
    J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
    Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen.
    St-Arnaud R; Lachance R; Kelly SJ; Belanger A; Dupont A; Labrie F
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):21-30. PubMed ID: 3519004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility.
    Sheehan KL; Casper RF; Yen SS
    Fertil Steril; 1982 Feb; 37(2):209-12. PubMed ID: 7037463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland.
    Simard J; Labrie C; Hubert JF; Labrie F
    Mol Endocrinol; 1988 Sep; 2(9):775-84. PubMed ID: 2459604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat testicular steroidogenesis.
    D'Agata R; Cassorla F; Munabi AK; Mericq V; Gelato MC; Albertson BD; Loriaux DL
    Steroids; 1984 Feb; 43(2):201-7. PubMed ID: 6395451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients.
    Zorn JR; Mathieson J; Risquez F; Comaru-Schally AM; Schally AV
    Fertil Steril; 1990 Mar; 53(3):401-6. PubMed ID: 2137792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
    Rubio MA; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1989 Aug; 69(2):444-7. PubMed ID: 2526819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrapituitary action of LHRH and LHRH-like substance in the testes.
    Arimura A
    Hinyokika Kiyo; 1983 Aug; 29(8):1005-8. PubMed ID: 6326540
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.
    Redding TW; Schally AV; Tice TR; Meyers WE
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5845-8. PubMed ID: 6237365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
    Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D
    J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
    Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF
    N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-Trp6-luteinizing hormone-releasing hormone inhibits sulpiride-induced hyperprolactinemia in normal men.
    Rubio MA; Torres-Aleman I; Calle JR; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1987 Aug; 65(2):368-9. PubMed ID: 2954994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of gonadotropin secretion rate on the radiosensitivity of the rat luteinizing hormone-releasing hormone neuron and gonadotroph.
    Winterer J; Barnes KM; Lichter AS; Deluca AM; Loriaux DL; Cutler GB
    Endocrinology; 1988 Mar; 122(3):884-90. PubMed ID: 3125043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
    Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
    JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.
    Rosenthal SM; Grumbach MM; Kaplan SL
    J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.
    Klibanski A; Deutsch PJ; Jameson JL; Ridgway EC; Crowley WF; Hsu DW; Habener JF; Black PM
    J Clin Endocrinol Metab; 1987 Mar; 64(3):536-42. PubMed ID: 3102541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.